Produced by Araxis Merge on 2/14/2018 10:18:24 AM Eastern Standard Time. See www.araxis.com for information about Merge. This report uses XHTML and CSS2, and is best viewed with a modern standards-compliant browser. For optimum results when printing this report, use landscape orientation and enable printing of background images and colours in your browser.
| # | Location | File | Last Modified |
|---|---|---|---|
| 1 | FileMan DI_22.2_10.zip\FileMan DI_22.2_10 | DI_222_10 Regression Tests.docx | Tue Dec 19 21:21:52 2017 UTC |
| 2 | FileMan DI_22.2_10.zip\FileMan DI_22.2_10 | DI_222_10 Regression Tests.docx | Wed Feb 14 14:49:37 2018 UTC |
| Description | Between Files 1 and 2 |
|
|---|---|---|
| Text Blocks | Lines | |
| Unchanged | 1 | 666 |
| Changed | 0 | 0 |
| Inserted | 0 | 0 |
| Removed | 0 | 0 |
| Whitespace | |
|---|---|
| Character case | Differences in character case are significant |
| Line endings | Differences in line endings (CR and LF characters) are ignored |
| CR/LF characters | Not shown in the comparison detail |
No regular expressions were active.
| 1 | DI*22.2*10 REGRESSIO N TESTS | |
| 2 | Descriptio n: | |
| 3 | This patch corrects seven issu es with VA FileMan 2 2.2. The Regression Tests can only be p erformed o n the issu es that af fected cur rent use. The follo wing issue s will not be tested because n o current applicatio n utilizin g them: | |
| 4 | Change to DINIT4 rou tine | |
| 5 | New api EN ^DITP | |
| 6 | Deleting o f options | |
| 7 | New api CH KPT^DIUTL | |
| 8 | I. The D IWP api on ly support strings u p to 999 c haracters | |
| 9 | The DIWP a pi is used to format multiple strings of text. Th e input va riable X i s a string of text a nd DIWP on ly reads t he first 9 99 charact ers. This patch ext ends that restrictio n to 9999 characters . To veri fy this fi x has not adversely affected o ther FileM an text ut ilities, S creenMan a nd scroll mode Word Processing fields we re tested with text greater th an 999 cha racters. | |
| 10 | ||
| 11 | Date Teste d: 12/7/20 17 | |
| 12 | Tester: R on DiMicel i | |
| 13 | Build: D I*22.2*10 TEST v3 | |
| 14 | ||
| 15 | VA FileMan 22.2 | |
| 16 | ||
| 17 | ||
| 18 | Select OPT ION: ENTER OR EDIT F ILE ENTRIE S | |
| 19 | ||
| 20 | ||
| 21 | Input to w hat File: ZZRON1// (0 entri es) | |
| 22 | EDIT WHICH FIELD: AL L// TESTWO RD (wor d-processi ng) | |
| 23 | THEN EDIT FIELD: | |
| 24 | ||
| 25 | ||
| 26 | Select ZZR ON1 NAME: ONE | |
| 27 | Are you adding 'ON E' as a ne w ZZRON1 ( the 1ST)? No// Y (Y es) | |
| 28 | TESTWORD: | |
| 29 | 1>"Molec ular Patho logy Proce dure, Leve l 1 (Eg, I dentificat ion Of Sin gle Germli | |
| 30 | ne Variant [Eg, Snp] By Techni ques Such As Restric tion Enzym e Digestio n Or Melt | |
| 31 | Curve Anal ysis) Acad m (Acyl-Co a Dehydrog enase, C-4 To C-12 S traight Ch ain, Mcad) | |
| 32 | (Eg, Med | |
| 33 | 2>ium Ch ain Acyl D ehydrogena se Deficie ncy), K304 e Variant Ace (Angio tensin Con | |
| 34 | verting En zyme) (Eg, Hereditar y Blood Pr essure Reg ulation), Insertion/ Deletion V | |
| 35 | ariant Agt r1 (Angiot ensin Ii R eceptor, T ype 1) (Eg , Essentia l Hyperten sion), 116 | |
| 36 | 6a>C Vari | |
| 37 | 3>ant Bc kdha (Bran ched Chain Keto Acid Dehydroge nase E1, A lpha Polyp eptide) (E | |
| 38 | g, Maple S yrup Urine Disease, Type 1a), Y438n Vari ant Ccr5 ( Chemokine C-C Motif | |
| 39 | Receptor 5 ) (Eg, Hiv Resistanc e), 32-Bp Deletion M utation/79 4 825del32 Deletion | |
| 40 | Clrn1 (Cl | |
| 41 | 4>arin 1 ) (Eg, Ush er Syndrom e, Type 3) , N48k Var iant Dpyd (Dihydropy rimidine D | |
| 42 | ehydrogena se) (Eg, 5 -Fluoroura cil/5-Fu A nd Capecit abine Drug Metabolis m), Ivs14+ | |
| 43 | 1g>A Varia nt F2 (Coa gulation F actor 2) ( Eg, Heredi tary Hyper coagulabil ity), 1199 | |
| 44 | g>A Varia | |
| 45 | 5>nt F5 (Coagulati on Factor V) (Eg, He reditary H ypercoagul ability), Hr2 Varian | |
| 46 | t F7 (Coag ulation Fa ctor Vii [ Serum Prot hrombin Co nversion A ccelerator ]) (Eg, He | |
| 47 | reditary H ypercoagul ability), R353q Vari ant F13b ( Coagulatio n Factor X iii, B Pol | |
| 48 | ypeptide) | |
| 49 | 6> (Eg, Hereditary Hypercoag ulability) , V34l Var iant Fgb ( Fibrinogen Beta Chai | |
| 50 | n) (Eg, He reditary I schemic He art Diseas e), -455g> A Variant Fgfr1 (Fib roblast Gr | |
| 51 | owth Facto r Receptor 1) (Eg, P feiffer Sy ndrome Typ e 1, Crani osynostosi s), P252r | |
| 52 | Variant F | |
| 53 | 7>gfr3 ( Fibroblast Growth Fa ctor Recep tor 3) (Eg , Muenke S yndrome), P250r Vari | |
| 54 | ant Fktn ( Fukutin) ( Eg, Fukuya ma Congeni tal Muscul ar Dystrop hy), Retro transposon | |
| 55 | Insertion Variant G ne (Glucos amine [Udp -N-Acetyl] -2-Epimera se/N-Acety lmannosami | |
| 56 | ne Kinase | |
| 57 | 8>) (Eg, Inclusion Body Myop athy 2 [Ib m2], Nonak a Myopathy ), M712t V ariant Hum | |
| 58 | an Platele t Antigen 1 Genotypi ng (Hpa-1) , Itgb3 (I ntegrin, B eta 3 [Pla telet Glyc | |
| 59 | oprotein I iia], Anti gen Cd61 [ Gpiiia]) ( Eg, Neonat al Alloimm une Thromb ocytopenia | |
| 60 | [Nait], | |
| 61 | 9>Post-T ransfusion Purpura), Hpa-1a/B (L33p) Hum an Platele t Antigen 2 Genotypi | |
| 62 | ng (Hpa-2) , Gp1ba (G lycoprotei n Ib [Plat elet], Alp ha Polypep tide [Gpib a]) (Eg, N | |
| 63 | eonatal Al loimmune T hrombocyto penia [Nai t], Post-T ransfusion Purpura), Hpa-2a/B | |
| 64 | (T145m) H | |
| 65 | 10>uman P latelet An tigen 3 Ge notyping ( Hpa-3), It ga2b (Inte grin, Alph a 2b [Plat | |
| 66 | elet Glyco protein Ii b Of Iib/I iia Comple x], Antige n Cd41 [Gp iib]) (Eg, Neonatal | |
| 67 | Alloimmune Thrombocy topenia [N ait], Post -Transfusi on Purpura ), Hpa-3a/ B (I843s) | |
| 68 | Human Pla | |
| 69 | 11>telet Antigen 4 Genotyping (Hpa-4), Itgb3 (Int egrin, Bet a 3 [Plate let Glycop | |
| 70 | rotein Iii a], Antige n Cd61 [Gp iiia]) (Eg , Neonatal Alloimmun e Thromboc ytopenia [ | |
| 71 | Nait], Pos t-Transfus ion Purpur a), Hpa-4a /B (R143q) Human Pla telet Anti gen 5 Geno | |
| 72 | typing (H | |
| 73 | 12>pa-5), Itga2 (In tegrin, Al pha 2 [Cd4 9b, Alpha 2 Subunit Of Vla-2 R eceptor] [ | |
| 74 | Gpia]) (Eg , Neonatal Alloimmun e Thromboc ytopenia [ Nait], Pos t-Transfus ion Purpur | |
| 75 | a), Hpa-5a /B (K505e) Human Pla telet Anti gen 6 Geno typing (Hp a-6w), Itg b3 (Integr | |
| 76 | in, Beta | |
| 77 | 13>3 [Pla telet Glyc oprotein I iia, Antig en Cd61] [ Gpiiia]) ( Eg, Neonat al Alloimm | |
| 78 | une Thromb ocytopenia [Nait], P ost-Transf usion Purp ura), Hpa- 6a/B (R489 q) Human P | |
| 79 | latelet An tigen 9 Ge notyping ( Hpa-9w), I tga2b (Int egrin, Alp ha 2b [Pla telet Glyc | |
| 80 | oprotein | |
| 81 | 14>Iib Of Iib/Iiia Complex, A ntigen Cd4 1] [Gpiib] ) (Eg, Neo natal Allo immune Thr | |
| 82 | ombocytope nia [Nait] , Post-Tra nsfusion P urpura), H pa-9a/B (V 837m) Huma n Platelet | |
| 83 | Antigen 1 5 Genotypi ng (Hpa-15 ), Cd109 ( Cd109 Mole cule) (Eg, Neonatal Alloimmune | |
| 84 | Thromboc | |
| 85 | 15>ytopen ia [Nait], Post-Tran sfusion Pu rpura), Hp a-15a/B (S 682y) Il28 b (Interle | |
| 86 | ukin 28b [ Interferon , Lambda 3 ]) (Eg, Dr ug Respons e), Rs1297 9860 Varia nt Ivd (Is | |
| 87 | ovaleryl-C oa Dehydro genase) (E g, Isovale ric Acidem ia), A282v Variant L ct (Lactas | |
| 88 | e-Phloriz | |
| 89 | 16>in Hyd rolase) (E g, Lactose Intoleran ce), 13910 C>T Varia nt Neb (Ne bulin) (Eg | |
| 90 | , Nemaline Myopathy 2), Exon 5 5 Deletion Variant P cdh15 (Pro tocadherin -Related 1 | |
| 91 | 5) (Eg, Us her Syndro me Type 1f ), R245x V ariant Ser pine1 (Ser pine Pepti dase Inhib | |
| 92 | itor Clad | |
| 93 | 17>e E, M ember 1, P lasminogen Activator Inhibitor -1, Pai-1 ) (Eg, Thr ombophilia | |
| 94 | ), 4g Vari ant SHOC2 (Soc-2 Sup pressor of Clear Hom olog) (eg, Noonan-li ke Syndrom | |
| 95 | e with Loo se Anagn H air), s2g Variant SL CO1B1 (Sol ute Carrie r Organic Anion Tran | |
| 96 | sporter F | |
| 97 | 18>amily, Member 1B 1) (eg, Ad verse Drug Reaction) , v174a Va riant SMN1 (Survival | |
| 98 | of Motor Neuron 1, Telomeric) (eg, Spin al Muscula r Atrophy) , Exon 7 D eletion SR | |
| 99 | Y (Sex Det ermining R egion Y) ( eg, 46,XX Testicular Disorder of Sex Dev elopment, | |
| 100 | Gonadal D | |
| 101 | 19>ysgene sis), Gene Analysis tor1a (Tor sin Family 1, Member A [Torsin A]) (eg, | |
| 102 | Early-Onse t Primary Dystonia [ DYT1]), 90 7_909DELGA G (904_906 DELGAG) Va riant" | |
| 103 | 20> | |
| 104 | EDIT Optio n: | |
| 105 | ||
| 106 | ||
| 107 | Select ZZR ON1 NAME: | |
| 108 | ||
| 109 | ||
| 110 | Result: Pa ssed | |
| 111 | ||
| 112 | ||
| 113 | Date Teste d: 12/7/20 17 | |
| 114 | Tester: R on DiMicel i | |
| 115 | Build: D I*22.2*10 TEST v3 | |
| 116 | ||
| 117 | VA FileMan 22.2 | |
| 118 | ||
| 119 | ||
| 120 | Select OPT ION: OT HER OPTION S | |
| 121 | Select OTH ER OPTION: SCREEN MAN | |
| 122 | Select SCR EENMAN OPT ION: RUN A FORM | |
| 123 | ||
| 124 | Run Form f rom what F ile: ZZRON 1// (1 entry ) | |
| 125 | ||
| 126 | Select FOR M: RON1 R ON1 (NOV 28, 2 017@13:23) User #1114 File #500 005 | |
| 127 | ||
| 128 | Select ZZR ON1 NAME: TWO | |
| 129 | Are you adding 'TW O' as a ne w ZZRON1 ( the 2ND)? No// Y (Y es) | |
| 130 | TESTWORD: | |
| 131 | ||
| 132 | ==[ WRAP ] ==[INSERT ]========= ======< TE STWORD >== ===[Press <PF1>H for help]==== | |
| 133 | (Eg, Neona tal Alloim mune Throm bocytopeni a [Nait], Post-Trans fusion | |
| 134 | Purpura), Hpa-15a/B (S682y) Il 28b (Inter leukin 28b [Interfer on, Lambda | |
| 135 | 3]) (Eg, D rug Respon se), Rs129 79860 Vari ant Ivd (I sovaleryl- Coa | |
| 136 | Dehydrogen ase) (Eg, Isovaleric Acidemia) , A282v Va riant Lct | |
| 137 | (Lactase-P hlorizin H ydrolase) (Eg, Lacto se Intoler ance), 139 10 C>T | |
| 138 | Variant Ne b (Nebulin ) (Eg, Nem aline Myop athy 2), E xon 55 Del etion Vari ant | |
| 139 | Pcdh15 (Pr otocadheri n-Related 15) (Eg, U sher Syndr ome Type 1 f), R245x | |
| 140 | Variant Se rpine1 (Se rpine Pept idase Inhi bitor Clad e E, Membe r 1, | |
| 141 | Plasminoge n Activato r Inhibito r -1, Pai- 1) (Eg, Th rombophili a), 4g | |
| 142 | Variant SH OC2 (Soc-2 Suppresso r of Clear Homolog) (eg, Noona n-like | |
| 143 | Syndrome w ith Loose Anagn Hair ), s2g Var iant SLCO1 B1 (Solute Carrier | |
| 144 | Organic An ion Transp orter Fami ly, Member 1B1) (eg, Adverse D rug | |
| 145 | Reaction), v174a Var iant SMN1 (Survival of Motor N euron 1, T elomeric) | |
| 146 | (eg, Spina l Muscular Atrophy), Exon 7 De letion SRY (Sex Dete rmining | |
| 147 | Region Y) (eg, 46,XX Testicula r Disorder of Sex De velopment, Gonadal | |
| 148 | Dysgenesis ), Gene An alysis tor 1a (Torsin Family 1, Member A [Torsin A] ) | |
| 149 | (eg, Early -Onset Pri mary Dysto nia [DYT1] ), 907_909 DELGAG (90 4_906DELGA G) | |
| 150 | Variant" | |
| 151 | ||
| 152 | <=======T= ======T=== ====T===== ==T======= T=======T= ======T=== ====T===== ==T>====== | |
| 153 | ||
| 154 | ||
| 155 | ||
| 156 | ||
| 157 | ||
| 158 | Select ZZR ON1 NAME: | |
| 159 | ||
| 160 | ||
| 161 | Select OPT ION: | |
| 162 | ||
| 163 | Result: Pa ssed | |
| 164 | ||
| 165 | ||
| 166 | II. The %D T api does n’t return an error for incorr ect time w hen time i s required | |
| 167 | The %DT ap i is used in all fie lds that a re defined as type D ATE/TIME. To verify this fix hasn’t aff ected File Man fields , four DAT E/TIME typ e fields w ere tested from the FileMan En ter or Edi t File Ent ries optio n. Each D ate field allows tim e and will be tested first wit h an incor rect time and then a correct t ime. | |
| 168 | ||
| 169 | Date Teste d: 12/7/20 17 | |
| 170 | Tester: R on DiMicel i | |
| 171 | Build: D I*22.2*10 TEST v3 | |
| 172 | ||
| 173 | Data Dicti onary List File Attr ibutes for the four fields: | |
| 174 | ||
| 175 | 16000046,2 DATE1 0;2 DATE | |
| 176 | ||
| 177 | INPUT TRANSFORM: S %DT="E TX" D ^%DT S X=Y K:Y <1 X | |
| 178 | LAST E DITED: NOV 30, 2017 | |
| 179 | ||
| 180 | 16000046,3 DATE2 0;3 DATE | |
| 181 | ||
| 182 | INPUT TRANSFORM: S %DT="E T" D ^%DT S X=Y K:Y< 1 X | |
| 183 | LAST E DITED: NOV 30, 2017 | |
| 184 | ||
| 185 | 16000046,4 DATE3 0;4 DATE | |
| 186 | ||
| 187 | INPUT TRANSFORM: S %DT="E STXR" D ^% DT S X=Y K :Y<1 X | |
| 188 | LAST E DITED: NOV 30, 2017 | |
| 189 | ||
| 190 | 16000046,5 DATE4 0;5 DATE | |
| 191 | ||
| 192 | INPUT TRANSFORM: S %DT="E STX" D ^%D T S X=Y K: Y<1 X | |
| 193 | LAST E DITED: NOV 30, 2017 | |
| 194 | ||
| 195 | ||
| 196 | ||
| 197 | VA FileMan 22.2 | |
| 198 | ||
| 199 | ||
| 200 | Select OPT ION: | |
| 201 | Select OPT ION: enter OR EDIT F ILE ENTRIE S | |
| 202 | ||
| 203 | ||
| 204 | ||
| 205 | Input to w hat File: RON TEST5/ / (3 entri es) | |
| 206 | EDIT WHICH FIELD: AL L// 2 DAT E1 | |
| 207 | THEN EDIT FIELD: 3 DATE2 | |
| 208 | THEN EDIT FIELD: 4 DATE3 | |
| 209 | THEN EDIT FIELD: 5 DATE4 | |
| 210 | THEN EDIT FIELD: | |
| 211 | ||
| 212 | Select RON TEST5 NAM E: DIMI CELI,RONAL D | |
| 213 | DATE1: T@2 601?? | |
| 214 | Examples o f Valid Da tes: | |
| 215 | JAN 20 1957 or 20 JAN 57 or 1/20/57 o r 012057 (omitting punctuatio n) | |
| 216 | T (fo r TODAY), T+1 (for TOMORROW), T+2, T+ 7, etc. | |
| 217 | T-1 (fo r YESTERDA Y), T-3W (for 3 WEE KS AGO), e tc. | |
| 218 | If the yea r is omitt ed, the co mputer use s CURRENT YEAR. | |
| 219 | A 2-digit year means no more t han 20 yea rs in the future, or 80 years in | |
| 220 | the past. | |
| 221 | ||
| 222 | If the dat e is omitt ed, the cu rrent date is assume d. | |
| 223 | Follow the date with a time, s uch as JAN 20@10, T@ 10AM, 10:3 0, etc. | |
| 224 | You may en ter NOON, MIDNIGHT, or NOW to indicate t he time. | |
| 225 | DATE1: T@2 315 (DEC 07, 2017@2 3:15) | |
| 226 | DATE2: T@2 601?? | |
| 227 | Examples o f Valid Da tes: | |
| 228 | JAN 20 1957 or 20 JAN 57 or 1/20/57 o r 012057 (omitting punctuatio n) | |
| 229 | T (fo r TODAY), T+1 (for TOMORROW), T+2, T+ 7, etc. | |
| 230 | T-1 (fo r YESTERDA Y), T-3W (for 3 WEE KS AGO), e tc. | |
| 231 | If the yea r is omitt ed, the co mputer use s CURRENT YEAR. | |
| 232 | A 2-digit year means no more t han 20 yea rs in the future, or 80 years in | |
| 233 | the past. | |
| 234 | You may om it the pre cise day o f the mont h, e.g.: J an, 1957 | |
| 235 | ||
| 236 | If the dat e is omitt ed, the cu rrent date is assume d. | |
| 237 | Follow the date with a time, s uch as JAN 20@10, T@ 10AM, 10:3 0, etc. | |
| 238 | You may en ter NOON, MIDNIGHT, or NOW to indicate t he time. | |
| 239 | DATE2: T@2 315 (DEC 07, 2017@2 3:15) | |
| 240 | DATE3: T@2 601?? | |
| 241 | Examples o f Valid Da tes: | |
| 242 | JAN 20 1957 or 20 JAN 57 or 1/20/57 o r 012057 (omitting punctuatio n) | |
| 243 | T (fo r TODAY), T+1 (for TOMORROW), T+2, T+ 7, etc. | |
| 244 | T-1 (fo r YESTERDA Y), T-3W (for 3 WEE KS AGO), e tc. | |
| 245 | If the yea r is omitt ed, the co mputer use s CURRENT YEAR. | |
| 246 | A 2-digit year means no more t han 20 yea rs in the future, or 80 years in | |
| 247 | the past. | |
| 248 | ||
| 249 | If the dat e is omitt ed, the cu rrent date is assume d. | |
| 250 | Follow the date with a time, s uch as JAN 20@10, T@ 10AM, 10:3 0, etc. | |
| 251 | You may en ter NOON, MIDNIGHT, or NOW to indicate t he time. | |
| 252 | Seconds ma y be enter ed, as e.g .: 10:30:3 0 or 1030 30AM | |
| 253 | Time is RE QUIRED to be entered . | |
| 254 | DATE3: T@2 315 (DEC 07, 2017@2 3:15:00) | |
| 255 | DATE4: T@2 601?? | |
| 256 | Examples o f Valid Da tes: | |
| 257 | JAN 20 1957 or 20 JAN 57 or 1/20/57 o r 012057 (omitting punctuatio n) | |
| 258 | T (fo r TODAY), T+1 (for TOMORROW), T+2, T+ 7, etc. | |
| 259 | T-1 (fo r YESTERDA Y), T-3W (for 3 WEE KS AGO), e tc. | |
| 260 | If the yea r is omitt ed, the co mputer use s CURRENT YEAR. | |
| 261 | A 2-digit year means no more t han 20 yea rs in the future, or 80 years in | |
| 262 | the past. | |
| 263 | ||
| 264 | If the dat e is omitt ed, the cu rrent date is assume d. | |
| 265 | Follow the date with a time, s uch as JAN 20@10, T@ 10AM, 10:3 0, etc. | |
| 266 | You may en ter NOON, MIDNIGHT, or NOW to indicate t he time. | |
| 267 | Seconds ma y be enter ed, as e.g .: 10:30:3 0 or 1030 30AM | |
| 268 | DATE4: T@2 315 (DEC 07, 2017@2 3:15:00) | |
| 269 | ||
| 270 | ||
| 271 | Select RON TEST5 NAM E: | |
| 272 | ||
| 273 | ||
| 274 | Result: Pa ssed | |
| 275 | ||
| 276 | ||
| 277 | III. The v ariable DO is not ki lled after a call to DIE | |
| 278 | The DIE ap i is used to edit fi elds in an y file. T o verify t his fix ha sn’t affec ted editin g capabili ties, the DO variabl e will be set before editing f ields in a file. | |
| 279 | ||
| 280 | Date Teste d: 12/7/20 17 | |
| 281 | Tester: R on DiMicel i | |
| 282 | Build: D I*22.2*10 TEST v3 | |
| 283 | ||
| 284 | KRN>S DO=1 | |
| 285 | ||
| 286 | KRN>D ^DII | |
| 287 | ||
| 288 | ||
| 289 | VA FileMan 22.2 | |
| 290 | ||
| 291 | ||
| 292 | Select OPT ION: ENTER OR EDIT F ILE ENTRIE S | |
| 293 | ||
| 294 | ||
| 295 | Input to w hat File: RON TEST5/ / (3 entri es) | |
| 296 | EDIT WHICH FIELD: AL L// | |
| 297 | ||
| 298 | ||
| 299 | Select RON TEST5 NAM E: CLAR KE,KYLE E | |
| 300 | NAME: CLAR KE,KYLE E/ / | |
| 301 | Select MUL NUM: 2// 1 | |
| 302 | Are you adding '1' as a new MULNUM (th e 2ND for this RON T EST5)? No/ / Y (Yes) | |
| 303 | Select MUL NUM: ? | |
| 304 | Answer with MULN UM | |
| 305 | Choose from: | |
| 306 | 1 | |
| 307 | 2 | |
| 308 | ||
| 309 | Yo u may ente r a new MU LNUM, if y ou wish | |
| 310 | Ty pe a numbe r between 1 and 9999 , 0 decima l digits. | |
| 311 | ||
| 312 | Select MUL NUM: | |
| 313 | DATE1: NOW (DEC 07, 2017@11:5 8) | |
| 314 | DATE2: NOW (DEC 07, 2017@11:5 8) | |
| 315 | DATE3: NOW (DEC 07, 2017@11:5 8:36) | |
| 316 | DATE4: NOW (DEC 07, 2017@11:5 8:37) | |
| 317 | ||
| 318 | ||
| 319 | Select RON TEST5 NAM E: | |
| 320 | ||
| 321 | ||
| 322 | ||
| 323 | ||
| 324 | Select OPT ION: | |
| 325 | KRN>W DO | |
| 326 | ||
| 327 | W DO | |
| 328 | ^ | |
| 329 | <UNDEFINED > *DO | |
| 330 | KRN> | |
| 331 | ||
| 332 | Result: Pa ssed | |
| 333 |
Araxis Merge (but not the data content of this report) is Copyright © 1993-2016 Araxis Ltd (www.araxis.com). All rights reserved.